Log In
BCIQ
Print this Print this
 

OZ439/Piperaquine

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSmall molecule combination of piperaquine and OZ439
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationMalaria
Indication DetailsTreat malaria
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/05/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today